Specific targeting of retrocochlear auditory pathway for optimal pharmacotherapy delivery using a mouse model

Area of Science:

• Neuroscience
• Auditory system research
• Pharmacology

Background:

• Sensorineural hearing loss (SNHL) involves neural degeneration, necessitating targeted drug delivery for effective treatment.
• Accurate localization of drug delivery is crucial for successful therapeutic interventions in the auditory pathway.
• Safe and reliable methods are needed to deliver pharmacotherapies to specific inner ear structures.

Purpose of the Study:

• To compare the efficacy of three FluoroGold (FG) delivery methods for tracing the retrocochlear auditory pathway.
• To determine the most reproducible and specific method for delivering neuronal tracers to auditory structures.
• To evaluate the potential of FG as a tool for comparing pharmacotherapy delivery methods.

Main Methods:

• Three delivery methods (intratympanic (IT), intracochlear (IC), and round window (RW)) of FluoroGold (FG) were tested in CBA mice.
• FG, a retrograde neuronal tracer, was administered via IT, IC, or RW routes.
• Mice were sacrificed after five days, and cell counts were performed in the cochlear nucleus (CN), superior olivary complex (SOC), and lateral lemniscus (LL).

Main Results:

• Intratympanic (IT) injection demonstrated reproducible and specific labeling of neurons in the CN, SOC, and LL.
• Intracochlear (IC) and round window (RW) methods resulted in non-specific cell staining, hindering accurate cell count establishment.
• The IT method yielded average cell counts of 851 ± 121 (CN), 2629 ± 367 (SOC), and 112 ± 30 (LL).

Conclusions:

• Intratympanic (IT) injection is a superior method for achieving reproducible and specific neuronal cell staining in the retrocochlear auditory pathway.
• The IT route offers advantages over RW and IC delivery for tracing neural pathways in the auditory system.
• This finding supports the IT method as a reliable approach for future auditory pharmacotherapy research.